Oriental Land Co., Ltd. (OLCLY)
OTCMKTS · Delayed Price · Currency is USD
21.31
+0.75 (3.63%)
Aug 1, 2025, 3:56 PM EDT

SpringWorks Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2021
Period Ending
Aug '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2021
34,57732,23152,52455,78963,40949,221
Upgrade
Market Cap Growth
-17.28%-38.64%-5.85%-12.02%28.82%17.07%
Upgrade
Enterprise Value
33,49831,25851,60555,54163,43548,319
Upgrade
Last Close Price
20.5619.9431.9133.6639.3631.73
Upgrade
PE Ratio
39.2238.8766.0891.86954.51-
Upgrade
PS Ratio
7.187.1012.8515.3527.9331.91
Upgrade
PB Ratio
4.994.948.378.9410.187.16
Upgrade
P/TBV Ratio
5.075.028.519.1310.437.33
Upgrade
P/FCF Ratio
-50.6253.2093.63--
Upgrade
P/OCF Ratio
-24.7040.1944.22141.02-
Upgrade
EV/Sales Ratio
7.266.8912.6215.2827.9431.33
Upgrade
EV/EBITDA Ratio
20.3419.7136.7946.87150.96-
Upgrade
EV/EBIT Ratio
28.3627.2047.1866.401112.06-
Upgrade
EV/FCF Ratio
-49.1052.2793.21--
Upgrade
Debt / Equity Ratio
0.270.270.220.290.320.25
Upgrade
Debt / EBITDA Ratio
-1.120.981.534.75-
Upgrade
Debt / FCF Ratio
-2.801.403.04--
Upgrade
Asset Turnover
0.510.490.480.420.260.17
Upgrade
Inventory Turnover
16.1717.2517.3615.6411.518.15
Upgrade
Quick Ratio
2.522.091.721.992.942.00
Upgrade
Current Ratio
2.732.231.832.163.182.26
Upgrade
Return on Equity (ROE)
-12.89%13.51%10.18%1.06%-6.86%
Upgrade
Return on Assets (ROA)
-7.70%8.07%6.06%0.41%-2.86%
Upgrade
Return on Capital (ROIC)
-8.96%9.28%6.72%0.45%-3.17%
Upgrade
Return on Capital Employed (ROCE)
14.40%14.30%14.90%10.60%0.70%-
Upgrade
Earnings Yield
2.55%2.57%1.51%1.09%0.10%-1.00%
Upgrade
FCF Yield
-1.98%1.88%1.07%-0.57%-2.49%
Upgrade
Dividend Yield
0.45%0.47%0.27%0.18%0.12%0.15%
Upgrade
Payout Ratio
-19.87%12.78%13.39%105.50%-
Upgrade
Buyback Yield / Dilution
-0.05%1.68%-0.02%0.80%-2.80%3.86%
Upgrade
Total Shareholder Return
0.41%2.15%0.25%0.98%-2.68%4.01%
Upgrade
Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.